Fulgent Genetics (FLGT) Stock Price, Quote, News & History

Q: How do I buy Fulgent Genetics (FLGT) stock?

You can purchase shares of Fulgent Genetics (NASDAQ:FLGT) through any online brokerage.View our list of the best stock brokerages

Q: Who are Fulgent Genetics (FLGT) competitors?

Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Holdings Inc (NASDAQ:AVAH), Prenetics Global Ltd (NASDAQ:PRE), Cross Country Healthcare Inc (NASDAQ:CCRN), Talkspace Inc (NASDAQ:TALK) and OPKO Health Inc (NASDAQ:OPK).

Q: What is the forecast, or price target, for Fulgent Genetics (FLGT) stock?

Fulgent Genetics has a consensus price target of $33.00.

Q: What is the current price for Fulgent Genetics (FLGT)?

The stock price for Fulgent Genetics (NASDAQ: FLGT) is $23.44 last updated February 6, 2026 at 4:30 PM EST.

Q: Does Fulgent Genetics (FLGT) pay a dividend?

There are no upcoming dividends for Fulgent Genetics.

Q: When is Fulgent Genetics (NASDAQ:FLGT) reporting earnings?

Fulgent Genetics does not have any upcoming earnings scheduled.

Q: Is Fulgent Genetics (FLGT) going to split?

There is no upcoming split for Fulgent Genetics.

Q: What sector and industry does Fulgent Genetics (FLGT) operate in?

Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Comments

Fulgent Genetics Inc (FLGT) Stock Price, Quote, News & History

FLGTNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$23.44

-0.27-1.14%

At close: Feb 6, 4:00 PM EST

$23.44

N/A

After Hours: Feb 6, 4:30 PM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$23.93

Close

$23.44

Volume / Avg.

310.21K / 264.91K

Day Range

$23.13 - $23.94

52 Wk Range

14.57 - 31.04

Market Cap

$724.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

9.8%

Days to Cover

7.35

Recent Fulgent Genetics Inc News

Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Why Is Fulgent Genetics Stock Moving Higher Today?

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<

Vandana Singh

Why Fulgent Genetics Shares Are Trading Higher Today

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.52M

Investing Cash Flow (TTM)

72.76M

Financing Cash Flow (TTM)

-14.58M

Free Cash Flow (TTM)

-19.85M

Capital Expenditure (TTM)

-21.37M

Net Change in Cash (TTM)

59.70M

Analyst Trends and Forecast

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$355.40M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.31

PB Ratio (TTM)

0.65

Earnings Yield % (TTM)

-5.90%

Earnings Yield % (FWD)

-0.30%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$36.42

Company Debt

Total Debt

$2.43M

LT Debt

$1.96M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$447.00K

Total Cash

$117.64M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$447.00K

Repayment of Debt (TTM)

-$918.00K

Key Statistics

Open

$23.93

Close

$23.44

Volume / Avg.

310.21K / 264.91K

Day Range

$23.13 - $23.94

52 Wk Range

14.57 - 31.04

Market Cap

$724.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

9.8%

Days to Cover

7.35

About

Sector

Health Care

Industry

Health Care Providers & Services

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The l...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Fulgent Genetics (FLGT) stock?

A

You can purchase shares of Fulgent Genetics (NASDAQ:FLGT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Fulgent Genetics (FLGT) competitors?

A

Other companies in Fulgent Genetics’s space includes: Aveanna Healthcare Holdings Inc (NASDAQ:AVAH), Prenetics Global Ltd (NASDAQ:PRE), Cross Country Healthcare Inc (NASDAQ:CCRN), Talkspace Inc (NASDAQ:TALK) and OPKO Health Inc (NASDAQ:OPK).

Q

What is the forecast, or price target, for Fulgent Genetics (FLGT) stock?

A

Fulgent Genetics has a consensus price target of $33.00.

Q

What is the current price for Fulgent Genetics (FLGT)?

A

The stock price for Fulgent Genetics (NASDAQ: FLGT) is $23.44 last updated February 6, 2026 at 4:30 PM EST.

Q

Does Fulgent Genetics (FLGT) pay a dividend?

A

There are no upcoming dividends for Fulgent Genetics.

Q

When is Fulgent Genetics (NASDAQ:FLGT) reporting earnings?

A

Fulgent Genetics does not have any upcoming earnings scheduled.

Q

Is Fulgent Genetics (FLGT) going to split?

A

There is no upcoming split for Fulgent Genetics.

Q

What sector and industry does Fulgent Genetics (FLGT) operate in?

A

Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

People Also Watch

Aveanna Healthcare Holdings Inc

Cross Country Healthcare Inc

InnovAge Holding Corp

SBC Medical Group Holdings Inc

NASDAQ:SBC

$4.54

%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$23.93

Close

$23.44

Volume / Avg.

310.21K / 264.91K

Day Range

$23.13 - $23.94

52 Wk Range

14.57 - 31.04

Market Cap

$724.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

9.8%

Days to Cover

7.35

Recent Fulgent Genetics Inc News

Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Why Is Fulgent Genetics Stock Moving Higher Today?

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<

Vandana Singh

Why Fulgent Genetics Shares Are Trading Higher Today

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.52M

Investing Cash Flow (TTM)

72.76M

Financing Cash Flow (TTM)

-14.58M

Free Cash Flow (TTM)

-19.85M

Capital Expenditure (TTM)

-21.37M

Net Change in Cash (TTM)

59.70M

Analyst Trends and Forecast

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$355.40M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.31

PB Ratio (TTM)

0.65

Earnings Yield % (TTM)

-5.90%

Earnings Yield % (FWD)

-0.30%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$36.42

Company Debt

Total Debt

$2.43M

LT Debt

$1.96M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$447.00K

Total Cash

$117.64M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$447.00K

Repayment of Debt (TTM)

-$918.00K

Key Statistics

Open

$23.93

Close

$23.44

Volume / Avg.

310.21K / 264.91K

Day Range

$23.13 - $23.94

52 Wk Range

14.57 - 31.04

Market Cap

$724.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

23

Short Interest

9.8%

Days to Cover

7.35

About

Sector

Health Care

Industry

Health Care Providers & Services

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The l...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry